Fermenta Biotech Ltd Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2023 As Per Regulation 33 Of The Listing Regulations

Fermenta Biotech Ltd Board Meeting Outcome for Outcome Of Board Meeting And Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)

Fermenta Biotech Ltd Approval Of The Composite Scheme Of Amalgamation And Arrangement Amongst DVK Investments Private Limited (Transferor Company 1) And Aegean Properties Limited (Transferor Company 2) And Fermenta Biotech Limited (Transferee Company) And Their Respective Sha

Fermenta Biotech Ltd Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Fermenta Biotech Ltd Execution Of Sale Deed